Dr. Tinoco Suarez is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
460 W 10th Ave
Columbus, OH 43210Phone+1 614-293-0463Fax+1 614-293-1704
Education & Training
University of Miami/Jackson Health SystemFellowship, Hematology and Medical Oncology, 2013 - 2016
MedStar Health/Harbor HospitalResidency, Internal Medicine, 2008 - 2011
National University of ColombiaClass of 2005
Certifications & Licensure
FL State Medical License 2011 - 2025
OH State Medical License 2016 - 2025- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 51 citationsNirogacestat, a γ-Secretase Inhibitor for Desmoid Tumors.Mrinal Gounder, Ravin Ratan, Thierry Alcindor, Patrick Schöffski, Winette T van der Graaf
The New England Journal of Medicine. 2023-03-09 - 13 citationsImmune checkpoint inhibitor-related thrombocytopenia: incidence, risk factors and effect on survivalTyler Haddad, Songzhu Zhao, Mingjia Li, Sandip H. Patel, Andrew Johns
Cancer Immunology, Immunotherapy. 2021-10-07 - 2 citationsVimseltinib versus placebo for tenosynovial giant cell tumour (MOTION): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.Hans Gelderblom, Vivek Bhadri, Silvia Stacchiotti, Sebastian Bauer, Andrew J Wagner
Lancet. 2024-06-22
Journal Articles
- Treatment with a Small Molecule Mutant IDH1 Inhibitor Suppresses Tumorigenic Activity and Decreases Production of the Oncometabolite 2-Hydroxyglutarate in Human Chondr...Luyuan Li, Ana C Paz, Breelyn A Wilky, Britt Johnson, Karina Galoian, Andrew Rosenberg, Guozhi Hu, Gabriel Tinoco, Olaf Bodamer, Jonathan C Trent, PloS one, 9/14/2015
- The biology and management of cartilaginous tumors: a role for targeting isocitrate dehydrogenase.Tinoco G, Wilky BA, Paz-Mejia A, Rosenberg A, Trent JC, Am Soc Clin Oncol Educ Book., 5/2015
Professional Memberships
- Member
- Member
- Member
- Member
- Member
Other Languages
- Spanish, Portuguese
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
